SEMA4D and neoplasm: We could elicit NF-κB activation in endothelial cells when treated by conditioned media from head and neck squamous cell carcinoma (HNSCC) cell lines expressing Sema4D and demonstrate activation of NF-κB in vivo in a tumor xenograft model.